-
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM -
Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the First-Line Treatment of Chronic Lymphocytic Leukemia in Brazil
Sep 9, 2025, 16:22 PM -
Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer
Sep 9, 2025, 16:22 PM -
Flexible Parametric Inference for Cause-Specific Hazard-Competing Risk Models Under Interval Censoring
Sep 9, 2025, 16:22 PM -
Identifying CKD As a Key Driver of CVD Deaths
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Adults With Dry Eye Disease in France: Insights From a Multicenter Observational Study
Sep 9, 2025, 16:22 PM -
Medium vs. Low Citrate Concentration in Continuous Kidney Replacement Therapy: Positive Budget Impact Through Total Cost of Ownership Assessment
Sep 9, 2025, 16:22 PM -
Mobility and Upper Extremity Function in Duchenne Muscular Dystrophy: A Longitudinal Survey Using PROMIS
Sep 9, 2025, 16:22 PM -
The Elusive PICO: Assessing Prediction in Joint Clinical Assessments (JCA): A Case Study in Soft Tissue Sarcoma (STS)
Sep 9, 2025, 16:22 PM -
Patient Access Delays in Multi-Indication Medicines: A Review of Health Technology Assessment Timelines
Sep 9, 2025, 16:22 PM -
Integrating Prospective and Retrospective Real-World Data to Construct External Comparator Arms: Novel Methods and Design Considerations
Sep 9, 2025, 16:22 PM -
Economic and Epidemiological Burden of Type 1 Diabetes In France
Sep 9, 2025, 16:22 PM -
Life-Years Lost Due to Regulatory and Reimbursement Delays: A Study of Oncology Drugs Across England, Scotland, and France, 2022-2024
Sep 9, 2025, 16:22 PM -
Differential Responsiveness and Minimally Important Difference of EQ-5D: Truth or Artifact?
Sep 9, 2025, 16:22 PM -
Use of a Nonparametric Bayesian Method to Model Health State Preferences: An Application to UAE EQ-5D-5L Valuations
Sep 9, 2025, 16:22 PM -
Signal Detection and Network Pharmacology Analysis of Paronychia Associated With eGFR Inhibitors
Sep 9, 2025, 16:22 PM -
Exploring Value in Healthcare: Patient Satisfaction in Spain Before and After the Pandemic
Sep 9, 2025, 16:22 PM -
Underlying Systemic Motifs That Prevent Diabetes Patients From Seeking and Utilizing Health Services in a Country With a High Prevalence of Diabetes
Sep 9, 2025, 16:22 PM -
Inpatient Cost of Managing Adverse Events (AEs) Associated With Immune Checkpoint Inhibitors (ICI) Approved for Advanced or Metastatic Cancers in the UK
Sep 9, 2025, 16:22 PM -
Empirical Comparison of Four Approaches for Generating Confidence Intervals Around Weighted Trial-Level Correlation
Sep 9, 2025, 16:22 PM
